We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
RPC (RES) Q4 Loss Narrower Than Estimates, Revenues Miss
Read MoreHide Full Article
RPC Inc’s (RES - Free Report) fourth-quarter 2019 loss of 7 cents was narrower than the Zacks Consensus Estimate of a loss of 10 cents on successful cost-containment efforts.
However, the bottom line compared unfavorably against the year-ago quarter’s earnings of 6 cents per share. The weakness can primarily be attributed to lower activity levels and pricing along with a smaller-fleet of pressure pumping equipment.
Total revenues of $236 million missed the Zacks Consensus Estimate of $242 million. Moreover, the top line declined from the year-ago quarter’s figure of $377 million.
Operating loss in the Technical Services segment totaled $17.1 million against the year-ago quarter’s profit of $19.8 million. The underperformance was mainly caused by lower pricing and activity levels.
Operating profit in the Support Services segment came in at $1.2 million, down from $2.5 million in the year-ago quarter. Seasonal weakness in most of the service lines hurt this segment.
Cost and Expenses
Cost of revenues contracted from $274.4 million in fourth-quarter 2018 to $176.8 million due to lower activity levels and cost-reduction actions.
Financials
RPC’s total capital expenditure in the December quarter of 2019 amounted to $41.4 million. As of Dec 31, the company had cash and cash equivalents of $50 million and no long-term debt.
Outlook
The slowdown in drilling activities in U.S. resources and persistent weakness in crude prices have hurt demand for oilfield services. Although the company has witnessed slight improvement in January and is finishing the month on a strong note, it is uncertain of how things will turn out in the near term.
Murphy Oil Corporation has trailing four-quarter positive earnings surprise of 37.4%, on average.
California Resources Corporation has trailing four-quarter positive earnings surprise of 711.1%, on average. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters.
Suncor Energy has trailing four-quarter positive earnings surprise of 2.2%, on average. The company’s earnings beat the consensus mark in two of the last four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
RPC (RES) Q4 Loss Narrower Than Estimates, Revenues Miss
RPC Inc’s (RES - Free Report) fourth-quarter 2019 loss of 7 cents was narrower than the Zacks Consensus Estimate of a loss of 10 cents on successful cost-containment efforts.
However, the bottom line compared unfavorably against the year-ago quarter’s earnings of 6 cents per share. The weakness can primarily be attributed to lower activity levels and pricing along with a smaller-fleet of pressure pumping equipment.
Total revenues of $236 million missed the Zacks Consensus Estimate of $242 million. Moreover, the top line declined from the year-ago quarter’s figure of $377 million.
RPC, Inc. Price, Consensus and EPS Surprise
RPC, Inc. price-consensus-eps-surprise-chart | RPC, Inc. Quote
Segmental Performance
Operating loss in the Technical Services segment totaled $17.1 million against the year-ago quarter’s profit of $19.8 million. The underperformance was mainly caused by lower pricing and activity levels.
Operating profit in the Support Services segment came in at $1.2 million, down from $2.5 million in the year-ago quarter. Seasonal weakness in most of the service lines hurt this segment.
Cost and Expenses
Cost of revenues contracted from $274.4 million in fourth-quarter 2018 to $176.8 million due to lower activity levels and cost-reduction actions.
Financials
RPC’s total capital expenditure in the December quarter of 2019 amounted to $41.4 million. As of Dec 31, the company had cash and cash equivalents of $50 million and no long-term debt.
Outlook
The slowdown in drilling activities in U.S. resources and persistent weakness in crude prices have hurt demand for oilfield services. Although the company has witnessed slight improvement in January and is finishing the month on a strong note, it is uncertain of how things will turn out in the near term.
Zacks Rank & Stocks to Consider
RPC currently carries a Zacks Rank #3 (Hold). Meanwhile, few better-ranked players in the energy space are Murphy Oil Corporation (MUR - Free Report) , California Resources Corporation (CRC - Free Report) and Suncor Energy (SU - Free Report) . All the stocks sport a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Murphy Oil Corporation has trailing four-quarter positive earnings surprise of 37.4%, on average.
California Resources Corporation has trailing four-quarter positive earnings surprise of 711.1%, on average. The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters.
Suncor Energy has trailing four-quarter positive earnings surprise of 2.2%, on average. The company’s earnings beat the consensus mark in two of the last four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>